Diabetic retinopathy (DR) is a blindness-causing disease which belongs to the group of neurodegenerative diseases. Neurodegeneration of the retina is a process, in which retinal neurons suffer irreversible damage. This study aimed to assess the involvement of neurotrophins (brain-derived neurotrophic factor [BDNF] and nerve growth factor [NGF]) in the pathogenesis of DR.
Methods
The study was performed using male Lewis rats with type 1 diabetes mellitus induced by streptozotocin, and the control group included rats without drug administration. In vivo examinations performed over four weeks included eye fundus imaging, measurement of intraocular pressure, and glycemia. After sacrifice, serum and eyeballs were harvested. Post-mortem analyses included a histopathological analysis of the retina and the measurement of BDNF and NGF levels in the serum and eyeball homogenate.
Results
In the experimental group, early-stage DR was confirmed, and changes in the retina were observed: diabetic rats had relatively thicker outer nuclear layers and relatively thinner inner plexiform layers. A lower level of BDNF was observed in the serum of rats with DR, while the level of NGF in the eyeball homogenate positively correlated with vascular changes.
Conclusions
The observed changes in the levels of neurotrophins in early-stage DR may indicate their involvement in the disease pathogenesis.
TeoZLThamYCYuM, et al.Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology2021; 128: 1580–1591. 20210501. DOI: 10.1016/j.ophtha.2021.04.027.
3.
SaeediPPetersohnISalpeaP, et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract2019; 157: 107843. 20190910. DOI: 10.1016/j.diabres.2019.107843.
KusuharaSFukushimaYOguraS, et al.Pathophysiology of diabetic retinopathy: the old and the new. dmj2018; 42: 364–376. DOI: https://doi.org/10.4093/dmj.2018.0182
6.
WongTYSunJKawasakiR, et al.Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology2018; 125: 1608–1622. 20180524. DOI: 10.1016/j.ophtha.2018.04.007.
BlairNPWanekJFelderAE, et al.Retinal oximetry and vessel diameter measurements with a commercially available scanning Laser ophthalmoscope in diabetic retinopathy. Invest Ophthalmol Vis Sci2017; 58: 5556–5563. DOI: https://doi.org/10.1167/iovs.17-21934
SachdevaMM. Retinal neurodegeneration in diabetes: an emerging concept in diabetic retinopathy. Curr Diab Rep2021; 21: 20211213. DOI: https://doi.org/10.1007/s11892-021-01428-x
14.
CohenSRGardnerTW. Diabetic Retinopathy and Diabetic Macular Edema.
15.
FudalejEJustyniarskaMKasarełłoK, et al.Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review. Ophthalmic Res2021; 64: 345–355. DOI: https://doi.org/10.1159/000514441
16.
BossJDSinghPKPandyaHK, et al.Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci2017; 58: 5594–5603. DOI: https://doi.org/10.1167/iovs.17-21973
17.
JohnsonECGuoYCepurnaWO, et al.Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp Eye Res2009; 88: 808–815. DOI: https://doi.org/10.1016/j.exer.2009.02.004
18.
KimuraANamekataKGuoX, et al.Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int J Mol Sci2016; 17: 20160920. DOI: https://doi.org/10.3390/ijms17091584
19.
SikorskaEWołoszDKasarełłoK, et al.Preparation and analysis of histological slides of rat and mouse eyeballs to evaluate the retina. JoVE2024; 210: e66663. DOI: doi:https://doi.org/10.3791/66663
20.
GohariniaMZareeiARahimiM, et al.Can allopurinol improve retinopathy in diabetic rats? Oxidative stress or uric acid; which one is the culprit?Res Pharm Sci2017; 12: 401–408. DOI: https://doi.org/10.4103/1735-5362.213985
21.
HeMLongPYanW, et al.ALDH2 Attenuates early-stage STZ-induced aged diabetic rats retinas damage via Sirt1/Nrf2 pathway. Life Sci2018; 215: 227–235. DOI: https://doi.org/10.1016/j.lfs.2018.10.019
22.
WangQCShengWYiCJ, et al.Retrobulbarly injecting nerve growth factor attenuates visual impairment in streptozotocin-induced diabetes rats. Int Ophthalmol2020; 40: 3501–3511. DOI: https://doi.org/10.1007/s10792-020-01537-8
23.
RyuSYasunamiY. The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. Transplantation1991; 52: 599–605. DOI: https://doi.org/10.1097/00007890-199110000-00004
NaharNMohamedSMustaphaNM, et al.Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model. Naunyn Schmiedebergs Arch Pharmacol2021; 394: 457–467. DOI: https://doi.org/10.1007/s00210-020-01989-w
26.
DorfmanDArandaMLRosensteinRE. Enriched environment protects the optic nerve from early diabetes-induced damage in adult rats. PLoS One2015; 10: e0136637. DOI: https://doi.org/10.1371/journal.pone.0136637
27.
ZhangLChuWZhengL, et al.Zinc oxide nanoparticles from Cyperus rotundus attenuates diabetic retinopathy by inhibiting NLRP3 inflammasome activation in STZ-induced diabetic rats. J Biochem Mol Toxicol2020; 34: e22583. DOI: https://doi.org/10.1002/jbt.22583
28.
SuQDongJZhangD, et al.Protective effects of the bilobalide on retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Appl Biochem Biotechnol2022; 194: 6407–6422. DOI: https://doi.org/10.1007/s12010-022-04012-5
29.
HaoJZhangHYuJ, et al.Methylene blue attenuates diabetic retinopathy by inhibiting NLRP3 inflammasome activation in STZ-induced diabetic rats. Ocul Immunol Inflamm2019; 27: 836–843. DOI: https://doi.org/10.1080/09273948.2018.1450516
30.
LiXYangYSongY, et al.Effect of shuangdan mingmu capsule on diabetic retinopathy in rats via regulation of miRNAs. Diabetes Metab Syndr Obes2022; 15: 3181–3194. DOI: https://doi.org/10.2147/dmso.S379611
31.
ChaiGRLiuSYangHW, et al.Quercetin protects against diabetic retinopathy in rats by inducing heme oxygenase-1 expression. Neural Regen Res2021; 16: 1344–1350. DOI: https://doi.org/10.4103/1673-5374.301027
32.
BarberAJLiethEKhinSA, et al.Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest1998; 102: 783–791. DOI: https://doi.org/10.1172/jci2425
33.
YangZLiuQWenD, et al.Risk of diabetic retinopathy and retinal neurodegeneration in individuals with type 2 diabetes: beichen eye study. Front Endocrinol (Lausanne)2023; 14: 1098638. DOI: https://doi.org/10.3389/fendo.2023.1098638
34.
SungJYKimJJHwangJY, et al.Retinal neurodegeneration in diabetic retinopathy with systemic hypertension. Acta Diabetol2024; 61: 495–504. DOI: https://doi.org/10.1007/s00592-023-02226-5
35.
CamachoPRibeiroEPereiraB, et al.DNA Methyltransferase expression (DNMT1, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema response. Eur J Ophthalmol2023; 33: 2267–2274. DOI: https://doi.org/10.1177/11206721231171623
36.
ShenJHMaQShenSR, et al.Effect of α-linolenic acid on streptozotocin-induced diabetic retinopathy indices in vivo. Arch Med Res2013; 44: 514–520. DOI: https://doi.org/10.1016/j.arcmed.2013.09.010
37.
KimSTChungYYHwangHI, et al.Differential expression of BDNF and BIM in streptozotocin-induced diabetic rat retina after fluoxetine injection. In Vivo2021; 35: 1461–1466. DOI: https://doi.org/10.21873/invivo.12398
38.
FengYWangRXuJ, et al.Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats. Curr Eye Res2013; 38: 396–404. DOI: https://doi.org/10.3109/02713683.2012.748919
39.
DavarpanahMShokri-mashhadiNZiaeiR, et al.A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile. Sci Rep2021; 11: 13773. DOI: https://doi.org/10.1038/s41598-021-93271-z
40.
KrabbeKSNielsenARKrogh-MadsenR, et al.Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia2007; 50: 431–438. DOI: https://doi.org/10.1007/s00125-006-0537-4
41.
IuECYChanCB. Is brain-derived neurotrophic factor a metabolic hormone in peripheral tissues?Biology (Basel)2022; 11: 20220717. DOI: https://doi.org/10.3390/biology11071063
42.
AhmadMFNaseemNRahmanI, et al.Naringin attenuates the diabetic neuropathy in STZ-induced type 2 diabetic wistar rats. Life (Basel)2022; 12: 20221215. DOI: https://doi.org/10.3390/life12122111
43.
ZhangWXLinZQSunAL, et al.Curcumin ameliorates the experimental diabetic peripheral neuropathy through promotion of NGF expression in rats. Chem Biodivers2022; 19: e202200029. DOI: https://doi.org/10.1002/cbdv.202200029
44.
DalliTBekerMTerzioglu-UsakS, et al.Thymoquinone activates MAPK pathway in hippocampus of streptozotocin-treated rat model. Biomed Pharmacother2018; 99: 391–401. DOI: https://doi.org/10.1016/j.biopha.2018.01.047
45.
FicoERossoPTriacaV, et al.NGF Prevents loss of TrkA/VEGFR2 cells, and VEGF isoform dysregulation in the retina of adult diabetic rats. Cells2022; 11: 20221015. DOI: https://doi.org/10.3390/cells11203246
46.
ZhangWWangYKongJ, et al.Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Sci Rep2017; 7: 408. DOI: https://doi.org/10.1038/s41598-017-00298-2
47.
WangQ-CShengWYiC-J, et al.Retrobulbarly injecting nerve growth factor attenuates visual impairment in streptozotocin-induced diabetes rats. Int Ophthalmol2020; 40: 3501–3511. DOI: https://doi.org/10.1007/s10792-020-01537-8
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
